215 related articles for article (PubMed ID: 33623381)
1. Engineering of Neutrophil Membrane Camouflaging Nanoparticles Realizes Targeted Drug Delivery for Amplified Antitumor Therapy.
Wang J; Gu X; Ouyang Y; Chu L; Xu M; Wang K; Tong X
Int J Nanomedicine; 2021; 16():1175-1187. PubMed ID: 33623381
[TBL] [Abstract][Full Text] [Related]
2. Facile one-pot formulation of TRAIL-embedded paclitaxel-bound albumin nanoparticles for the treatment of pancreatic cancer.
Min SY; Byeon HJ; Lee C; Seo J; Lee ES; Shin BS; Choi HG; Lee KC; Youn YS
Int J Pharm; 2015 Oct; 494(1):506-15. PubMed ID: 26315118
[TBL] [Abstract][Full Text] [Related]
3. Lipoprotein-Inspired Nanocarrier Composed of Folic Acid-Modified Protein and Lipids: Preparation and Evaluation of Tumor-Targeting Effect.
Han M; Ji X; Li J; Ge Z; Luo B; Zhou K; Wang Q; Sun X; Zhang W; Li J
Int J Nanomedicine; 2020; 15():3433-3445. PubMed ID: 32523342
[TBL] [Abstract][Full Text] [Related]
4. Delta-like ligand 4-targeted nanomedicine for antiangiogenic cancer therapy.
Liu YR; Guan YY; Luan X; Lu Q; Wang C; Liu HJ; Gao YG; Yang SC; Dong X; Chen HZ; Fang C
Biomaterials; 2015 Feb; 42():161-71. PubMed ID: 25542804
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of a paclitaxel-loaded low molecular weight heparin-all-trans-retinoid acid conjugate ternary nanoparticulate drug delivery system.
Hou L; Yao J; Zhou J; Zhang Q
Biomaterials; 2012 Jul; 33(21):5431-40. PubMed ID: 22521488
[TBL] [Abstract][Full Text] [Related]
6. Lipid insertion enables targeted functionalization of paclitaxel-loaded erythrocyte membrane nanosystem by tumor-penetrating bispecific recombinant protein.
Chen H; Sha H; Zhang L; Qian H; Chen F; Ding N; Ji L; Zhu A; Xu Q; Meng F; Yu L; Zhou Y; Liu B
Int J Nanomedicine; 2018; 13():5347-5359. PubMed ID: 30254439
[TBL] [Abstract][Full Text] [Related]
7. The use of nanoparticulate delivery systems in metronomic chemotherapy.
Yu DH; Ban FQ; Zhao M; Lu Q; Lovell JF; Bai F; Wang C; Guan YY; Luan X; Liu YR; Fang C; Chen HZ
Biomaterials; 2013 May; 34(16):3925-3937. PubMed ID: 23465835
[TBL] [Abstract][Full Text] [Related]
8. Synergistic anti-cancer effects via co-delivery of TNF-related apoptosis-inducing ligand (TRAIL/Apo2L) and doxorubicin using micellar nanoparticles.
Lee AL; Dhillon SH; Wang Y; Pervaiz S; Fan W; Yang YY
Mol Biosyst; 2011 May; 7(5):1512-22. PubMed ID: 21350763
[TBL] [Abstract][Full Text] [Related]
9. Transformable DNA nanocarriers for plasma membrane targeted delivery of cytokine.
Sun W; Ji W; Hu Q; Yu J; Wang C; Qian C; Hochu G; Gu Z
Biomaterials; 2016 Jul; 96():1-10. PubMed ID: 27131597
[TBL] [Abstract][Full Text] [Related]
10. Targeting and microenvironment-improving of phenylboronic acid-decorated soy protein nanoparticles with different sizes to tumor.
Qian X; Ge L; Yuan K; Li C; Zhen X; Cai W; Cheng R; Jiang X
Theranostics; 2019; 9(24):7417-7430. PubMed ID: 31695777
[TBL] [Abstract][Full Text] [Related]
11. CGKRK-modified nanoparticles for dual-targeting drug delivery to tumor cells and angiogenic blood vessels.
Hu Q; Gao X; Kang T; Feng X; Jiang D; Tu Y; Song Q; Yao L; Jiang X; Chen H; Chen J
Biomaterials; 2013 Dec; 34(37):9496-508. PubMed ID: 24054848
[TBL] [Abstract][Full Text] [Related]
12. Bioinspired tumor-homing nanoplatform for co-delivery of paclitaxel and siRNA-E7 to HPV-related cervical malignancies for synergistic therapy.
Xu C; Liu W; Hu Y; Li W; Di W
Theranostics; 2020; 10(7):3325-3339. PubMed ID: 32194871
[TBL] [Abstract][Full Text] [Related]
13. Mesenchymal stem cells loaded with paclitaxel-poly(lactic-
Wang X; Gao J; Ouyang X; Wang J; Sun X; Lv Y
Int J Nanomedicine; 2018; 13():5231-5248. PubMed ID: 30237710
[TBL] [Abstract][Full Text] [Related]
14. Doxorubicin-loaded human serum albumin nanoparticles surface-modified with TNF-related apoptosis-inducing ligand and transferrin for targeting multiple tumor types.
Bae S; Ma K; Kim TH; Lee ES; Oh KT; Park ES; Lee KC; Youn YS
Biomaterials; 2012 Feb; 33(5):1536-46. PubMed ID: 22118776
[TBL] [Abstract][Full Text] [Related]
15. Polydopamine Nanoparticles Camouflaged by Stem Cell Membranes for Synergistic Chemo-Photothermal Therapy of Malignant Bone Tumors.
Zhang M; Zhang F; Liu T; Shao P; Duan L; Yan J; Mu X; Jiang J
Int J Nanomedicine; 2020; 15():10183-10197. PubMed ID: 33363374
[TBL] [Abstract][Full Text] [Related]
16. Anti-inflammatory mechanisms of neutrophil membrane-coated nanoparticles without drug loading.
Zhang Q; Hu C; Feng J; Long H; Wang Y; Wang P; Hu C; Yue Y; Zhang C; Liu Z; Zhou X
J Control Release; 2024 May; 369():12-24. PubMed ID: 38508526
[TBL] [Abstract][Full Text] [Related]
17. pH-Sensitive Biocompatible Nanoparticles of Paclitaxel-Conjugated Poly(styrene-co-maleic acid) for Anticancer Drug Delivery in Solid Tumors of Syngeneic Mice.
Dalela M; Shrivastav TG; Kharbanda S; Singh H
ACS Appl Mater Interfaces; 2015 Dec; 7(48):26530-48. PubMed ID: 26528585
[TBL] [Abstract][Full Text] [Related]
18. Glycyrrhizin-modified O-carboxymethyl chitosan nanoparticles as drug vehicles targeting hepatocellular carcinoma.
Shi L; Tang C; Yin C
Biomaterials; 2012 Oct; 33(30):7594-604. PubMed ID: 22796165
[TBL] [Abstract][Full Text] [Related]
19. Magnetic targeting of paclitaxel-loaded poly(lactic-
Ganipineni LP; Ucakar B; Joudiou N; Bianco J; Danhier P; Zhao M; Bastiancich C; Gallez B; Danhier F; Préat V
Int J Nanomedicine; 2018; 13():4509-4521. PubMed ID: 30127603
[TBL] [Abstract][Full Text] [Related]
20. Core-matched nanoassemblies for targeted co-delivery of chemotherapy and photosensitizer to treat drug-resistant cancer.
Jiang D; Xu M; Pei Y; Huang Y; Chen Y; Ma F; Lu H; Chen J
Acta Biomater; 2019 Apr; 88():406-421. PubMed ID: 30763634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]